Jean‐Pierre Bourquin

13.5k total citations
129 papers, 3.9k citations indexed

About

Jean‐Pierre Bourquin is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Jean‐Pierre Bourquin has authored 129 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 57 papers in Public Health, Environmental and Occupational Health and 55 papers in Hematology. Recurrent topics in Jean‐Pierre Bourquin's work include Acute Lymphoblastic Leukemia research (57 papers), Acute Myeloid Leukemia Research (41 papers) and CAR-T cell therapy research (26 papers). Jean‐Pierre Bourquin is often cited by papers focused on Acute Lymphoblastic Leukemia research (57 papers), Acute Myeloid Leukemia Research (41 papers) and CAR-T cell therapy research (26 papers). Jean‐Pierre Bourquin collaborates with scholars based in Switzerland, Germany and United States. Jean‐Pierre Bourquin's co-authors include Beat Bornhäuser, Dirk Reinhardt, Oleg Georgiev, Michael Dworzak, Martin Schrappe, Gunnar Cario, W. Schaffner, Ursula Creutzig, Bertrand Le Douarin and Peter Moosmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

Jean‐Pierre Bourquin

124 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Pierre Bourquin Switzerland 34 2.0k 1.3k 1.1k 889 522 129 3.9k
Ollivier Legrand France 31 1.3k 0.7× 1.5k 1.1× 567 0.5× 1.5k 1.7× 249 0.5× 93 3.2k
F Zintl Germany 37 1.2k 0.6× 1.2k 0.9× 1.2k 1.1× 1.3k 1.5× 605 1.2× 161 4.1k
Kajsa Paulsson Sweden 33 1.0k 0.5× 1.1k 0.8× 1.2k 1.1× 409 0.5× 482 0.9× 88 2.8k
Beverly S. Mitchell United States 46 3.6k 1.8× 1.0k 0.8× 890 0.8× 1.2k 1.3× 549 1.1× 125 5.7k
Leonid Karawajew Germany 30 1.1k 0.6× 828 0.6× 882 0.8× 573 0.6× 499 1.0× 82 2.4k
Daniela Cilloni Italy 33 1.6k 0.8× 2.7k 2.0× 783 0.7× 848 1.0× 292 0.6× 181 4.4k
José Andrés Yunes Brazil 30 1.7k 0.9× 486 0.4× 623 0.5× 566 0.6× 307 0.6× 129 3.1k
Lothar Bergmann Germany 39 2.1k 1.1× 1.4k 1.1× 571 0.5× 1.4k 1.5× 1.0k 2.0× 182 4.8k
William Blum United States 43 2.5k 1.3× 2.7k 2.1× 667 0.6× 1.3k 1.5× 1.0k 2.0× 188 5.6k
Daniel Steinbach Germany 26 1.1k 0.6× 497 0.4× 412 0.4× 943 1.1× 336 0.6× 69 2.3k

Countries citing papers authored by Jean‐Pierre Bourquin

Since Specialization
Citations

This map shows the geographic impact of Jean‐Pierre Bourquin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Bourquin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Bourquin more than expected).

Fields of papers citing papers by Jean‐Pierre Bourquin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Pierre Bourquin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Bourquin. The network helps show where Jean‐Pierre Bourquin may publish in the future.

Co-authorship network of co-authors of Jean‐Pierre Bourquin

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Bourquin. A scholar is included among the top collaborators of Jean‐Pierre Bourquin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Bourquin. Jean‐Pierre Bourquin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wangjie, Simona Bartimoccia, Bart Deplancke, et al.. (2025). A three-dimensional ex vivo model recapitulates in vivo features and drug resistance phenotypes in childhood acute lymphoblastic leukemia. Leukemia. 39(12). 2881–2894.
2.
Booth, Christopher A.G., Juliette Bouyssou, Katsuhiro Togami, et al.. (2024). BPDCN MYB fusions regulate cell cycle genes, impair differentiation, and induce myeloid–dendritic cell leukemia. JCI Insight. 9(24). 3 indexed citations
3.
Steffen, Ingo G., Christiane Chen‐Santel, Andrej Lissat, et al.. (2024). Prognostic relevance of treatment deviations in children with relapsed acute lymphoblastic leukemia who were treated in the ALL-REZ BFM 2002 study. Leukemia. 39(2). 337–345. 1 indexed citations
4.
Baccelli, Irène, Lennart Lenk, Beat Bornhäuser, et al.. (2023). Abstract 2957: CD127 is expressed by acute lymphoblastic leukemias and is efficiently targeted by the IL7R-antagonist OSE-127 through macrophage-mediated antibody dependent phagocytosis. Cancer Research. 83(7_Supplement). 2957–2957. 1 indexed citations
5.
Waespe, Nicolas, Fabiën N. Belle, Christina Schindera, et al.. (2021). Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study. European Journal of Cancer. 145. 71–80. 13 indexed citations
6.
Butler, Miriam, Dorette S. van Ingen Schenau, Jiangyan Yu, et al.. (2021). BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway. Blood. 138(23). 2383–2395. 17 indexed citations
7.
Otth, Maria, Sophie Yammine, Jakob Usemann, et al.. (2021). Longitudinal lung function in childhood cancer survivors after hematopoietic stem cell transplantation. Bone Marrow Transplantation. 57(2). 207–214. 4 indexed citations
8.
Rasche, Mareike, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2021). Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group. Cancers. 13(4). 789–789. 15 indexed citations
9.
Buijs-Gladdines, Jessica G. C. A. M., Valentina Cordo’, Willem K. Smits, et al.. (2021). MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia. 35(12). 3394–3405. 35 indexed citations
10.
Lissat, Andrej, Ingo G. Steffen, Jean‐Pierre Bourquin, et al.. (2021). Other (Non-CNS/Testicular) Extramedullary Localizations of Childhood Relapsed Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma—A Report from the ALL-REZ Study Group. Journal of Clinical Medicine. 10(22). 5292–5292. 3 indexed citations
11.
Aguadé-Gorgorió, Júlia, Scott McComb, Cornelia Eckert, et al.. (2020). TNFR2 is required for RIP1-dependent cell death in human leukemia. Blood Advances. 4(19). 4823–4833. 10 indexed citations
12.
Mezzatesta, Caterina, Anna Guinot, Cornelia Eckert, et al.. (2020). Repurposing anthelmintic agents to eradicate resistant leukemia. Blood Cancer Journal. 10(6). 72–72. 4 indexed citations
13.
Place, Andrew E., Kelly C. Goldsmith, Jean‐Pierre Bourquin, et al.. (2018). Accelerating Drug Development in Pediatric Cancer: A Novel Phase I Study Design of Venetoclax in Relapsed/Refractory Malignancies. Future Oncology. 14(21). 2115–2129. 39 indexed citations
14.
Jaeger-Ruckstuhl, Carla A., Tamara Hilmenyuk, Christina Claus, et al.. (2017). CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies. Blood. 130(3). 297–309. 32 indexed citations
15.
16.
Lehal, Rajwinder, Viktoras Frismantas, Jean‐Pierre Bourquin, et al.. (2017). Pharmacological Activity Of Cb-103-An Oral Pan-Notch Inhibitor With A Novel Mode Of Action. Haematologica. 102. 29–29. 1 indexed citations
17.
Peirs, Sofie, Viktoras Frismantas, Filip Matthijssens, et al.. (2016). Targeting BET family proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia. Haematologica. 101. 201–202. 1 indexed citations
18.
Creutzig, Ursula, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2013). Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood. 122(1). 37–43. 123 indexed citations
19.
Creutzig, Ursula, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2011). CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML‐BFM98 and 2004. Pediatric Blood & Cancer. 57(6). 986–992. 19 indexed citations
20.
Levy, Ofer, Jean‐Pierre Bourquin, Alisa McQueen, et al.. (2002). FATAL DISSEMINATED CANDIDA LUSITANIAE INFECTION IN AN INFANT WITH CHRONIC GRANULOMATOUS DISEASE. The Pediatric Infectious Disease Journal. 21(3). 262–264. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ollivier Legrand Breakdown of academic impact, for papers by F Zintl Breakdown of academic impact, for papers by Kajsa Paulsson Breakdown of academic impact, for papers by Beverly S. Mitchell Breakdown of academic impact, for papers by Leonid Karawajew Breakdown of academic impact, for papers by Daniela Cilloni Breakdown of academic impact, for papers by José Andrés Yunes Breakdown of academic impact, for papers by Lothar Bergmann Breakdown of academic impact, for papers by William Blum Breakdown of academic impact, for papers by Daniel Steinbach
Rankless by CCL
2026